CRA determined the commercial success of a pharmaceutical product used in the treatment of prostate cancer. CRA analyzed among other things, the relevant market including revenue, market share and marketing spend. CRA prepared an expert report, provided deposition testimony and testified at trial. The court found commercial success and cited the testimony of the CRA expert in the opinion.
At the nexus of commercial success and non-obviousness
Dr. Gregory K. Bell recently testified in three successful challenges to abbreviated new drug applications (ANDA) on behalf of pharmaceutical manufacturers...